These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3102961)
1. Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients. Streib EW Muscle Nerve; 1987 Feb; 10(2):155-62. PubMed ID: 3102961 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment with tocainide of recessive generalized congenital myotonia. Streib EW Ann Neurol; 1986 May; 19(5):501-4. PubMed ID: 3087270 [TBL] [Abstract][Full Text] [Related]
3. Clinical study of paramyotonia congenita with and without myotonia in a warm environment. Haass A; Ricker K; Rüdel R; Lehmann-Horn F; Böhlen R; Dengler R; Mertens HG Muscle Nerve; 1981; 4(5):388-95. PubMed ID: 6793868 [TBL] [Abstract][Full Text] [Related]
4. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Ricker K; Böhlen R; Rohkamm R Neurology; 1983 Dec; 33(12):1615-8. PubMed ID: 6417558 [TBL] [Abstract][Full Text] [Related]
5. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy. Jackson CE; Barohn RJ; Ptacek LJ Muscle Nerve; 1994 Jul; 17(7):763-8. PubMed ID: 8008003 [TBL] [Abstract][Full Text] [Related]
6. Distinguishing paramyotonia congenita and myotonia congenita by electromyography. Subramony SH; Malhotra CP; Mishra SK Muscle Nerve; 1983 Jun; 6(5):374-9. PubMed ID: 6888415 [TBL] [Abstract][Full Text] [Related]
7. [Paramyotonia congenita or Von Eulenburg syndrome]. Compernolle P; Bruyninckx F; Rosselle N Acta Belg Med Phys; 1989; 12(1):11-8. PubMed ID: 2501959 [No Abstract] [Full Text] [Related]
8. Adynamia episodica hereditaria: what causes the weakness? Ricker K; Camacho LM; Grafe P; Lehmann-Horn F; Rüdel R Muscle Nerve; 1989 Nov; 12(11):883-91. PubMed ID: 2558315 [TBL] [Abstract][Full Text] [Related]
9. Hypokalemic paralysis in two patients with paramyotonia congenita (PC) and known hyperkalemic/exercise-induced weakness. Streib EW Muscle Nerve; 1989 Nov; 12(11):936-7. PubMed ID: 2608088 [TBL] [Abstract][Full Text] [Related]
10. Effects of acetazolamide on myotonia. Griggs RC; Moxley RT; Riggs JE; Engel WK Ann Neurol; 1978 Jun; 3(6):531-7. PubMed ID: 677818 [TBL] [Abstract][Full Text] [Related]
13. Paramyotonia congenita: clinical and electrophysiologic studies. Streib EW; Sun SF; Hanson M Electromyogr Clin Neurophysiol; 1983; 23(4):315-25. PubMed ID: 6872931 [No Abstract] [Full Text] [Related]
14. Dose finding of tocainide in the treatment of tinnitus. Vermeij P; Hulshof JH Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):207-12. PubMed ID: 3086242 [TBL] [Abstract][Full Text] [Related]
15. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation. McKay OM; Krishnan AV; Davis M; Kiernan MC Clin Neurophysiol; 2006 Sep; 117(9):2064-8. PubMed ID: 16854622 [TBL] [Abstract][Full Text] [Related]
16. Potassium uptake in muscle during paramyotonic weakness. Moxley RT; Ricker K; Kingston WJ; Böhlen R Neurology; 1989 Jul; 39(7):952-5. PubMed ID: 2500620 [TBL] [Abstract][Full Text] [Related]
17. Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Colding-Jørgensen E; DunØ M; Schwartz M; Vissing J Muscle Nerve; 2003 Apr; 27(4):449-55. PubMed ID: 12661046 [TBL] [Abstract][Full Text] [Related]